Latest filing published 29 Dec 2020 for GenMark Diagnostics, Inc., €6,152. Read the official filing
All filings by Tyler Jensen on record concern GenMark Diagnostics, Inc. Over a trading history stretching from 21 May 2019 to 24 December 2020, the count stands at 32 filings.
No open-market purchase appears, only 29 sales worth €204k. Outside the open market, there are 2 share grants and 1 option exercise. 2020 to date brings no purchases and 22 sales.
The latest filing, published on 29 December 2020, reports an open-market sale of €6,152 in GenMark Diagnostics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 32 declarations